Publications by authors named "Shira Peress"
Article Synopsis
- Estrogen-containing contraceptives and hormone replacement therapies may increase the risk of venous thromboembolism (VTE) in patients with COVID-19, a risk that hasn't been studied much before.
- A study involving 991 patients showed that those on estrogen therapy had a significantly higher risk of VTE, particularly those over 50, with 8.6% diagnosed compared to 0.9% on non-estrogen therapies.
- These findings highlight the need for healthcare providers to be cautious in managing older patients on estrogen therapies during COVID-19, as they face a higher risk of complications.
The most common aortic arch abnormality is an aberrant right subclavian artery (ARSA). ARSA-esophageal fistula is a rare sequela that can present with a life-threatening upper gastrointestinal (GI) bleed. We report the case of an 88-year-old male who presented with signs of upper GI bleeding.
View Article and Find Full Text PDFPatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appear to be at increased risk for venous thromboembolism (VTE), especially if they become critically ill with COVID-19. Some centers have reported very high rates of thrombosis despite anticoagulant prophylaxis. The electronic health record (EHR) of a New Orleans-based health system was searched for all patients with polymerase chain reaction-confirmed SARS-CoV-2 infection who were either admitted to hospital or treated and discharged from an emergency department between 1 March 2020 and 1 May 2020.
View Article and Find Full Text PDF